Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Boehle

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
World Journal of Urology|October 6, 2006
Treatment options for BCG failuresMichael A O'Donnell, Andreas Boehle
Journal of Cancer Research and Clinical Oncology|January 28, 2021
Re: Results of a randomized trial of treatment modalities in patients with low or early‑intermediate risk prostate cancer (PREFERE trial)Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, et al.
Urologic Oncology|September 15, 2023
LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patientsAndreas Boehle, Dorothea Zywietz, Irina Robrahn-Nitschke, et al.
Advances in Radiation Oncology|February 27, 2023
Definitions of "Cure" After Low-Dose-Rate Brachytherapy in Low- and Intermediate-Risk Prostate Cancer: Phoenix or Surgical?Andreas Boehle, Dorothea Zywietz, Irina Robrahn-Nitschke, et al.
Brachytherapy|October 21, 2019
Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapyAndreas Boehle, Katharina Katic, Inke R König, et al.
European Urology|January 29, 2011
European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 updateMorgan Rouprêt, Richard Zigeuner, Juan Palou, et al.
Clinical Chemistry|July 28, 2004
Ki-67 protein concentrations in urothelial bladder carcinomas are related to Ki-67-specific RNA concentrations in urineTim B Menke, Katrin Boettcher, Stefan Krüger, et al.
European Urology|July 5, 2005
EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situAdrian P M van der Meijden, Richard Sylvester, Willem Oosterlinck, et al.
Nature Reviews. Urology|March 2, 2017
BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCGAshish M Kamat, Marc Colombel, Debasish Sundi, et al.
BJU International|January 18, 2020
Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)Justin T Matulay, Mark Soloway, J Alfred Witjes, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
World Journal of Urology|October 6, 2006
Treatment options for BCG failuresMichael A O'Donnell, Andreas Boehle
Journal of Cancer Research and Clinical Oncology|January 28, 2021
Re: Results of a randomized trial of treatment modalities in patients with low or early‑intermediate risk prostate cancer (PREFERE trial)Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, et al.
Urologic Oncology|September 15, 2023
LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patientsAndreas Boehle, Dorothea Zywietz, Irina Robrahn-Nitschke, et al.
Advances in Radiation Oncology|February 27, 2023
Definitions of "Cure" After Low-Dose-Rate Brachytherapy in Low- and Intermediate-Risk Prostate Cancer: Phoenix or Surgical?Andreas Boehle, Dorothea Zywietz, Irina Robrahn-Nitschke, et al.
Brachytherapy|October 21, 2019
Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapyAndreas Boehle, Katharina Katic, Inke R König, et al.
European Urology|January 29, 2011
European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 updateMorgan Rouprêt, Richard Zigeuner, Juan Palou, et al.
Clinical Chemistry|July 28, 2004
Ki-67 protein concentrations in urothelial bladder carcinomas are related to Ki-67-specific RNA concentrations in urineTim B Menke, Katrin Boettcher, Stefan Krüger, et al.
European Urology|July 5, 2005
EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situAdrian P M van der Meijden, Richard Sylvester, Willem Oosterlinck, et al.
Nature Reviews. Urology|March 2, 2017
BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCGAshish M Kamat, Marc Colombel, Debasish Sundi, et al.
BJU International|January 18, 2020
Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)Justin T Matulay, Mark Soloway, J Alfred Witjes, et al.
Pageof 2